Myomo Common Stock vs Current Deferred Revenue Analysis
MYO Stock | USD 3.64 0.04 1.09% |
Myomo financial indicator trend analysis is infinitely more than just investigating Myomo Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Myomo Inc is a good investment. Please check the relationship between Myomo Common Stock and its Current Deferred Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
Common Stock vs Current Deferred Revenue
Common Stock vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Myomo Inc Common Stock account and Current Deferred Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Myomo's Common Stock and Current Deferred Revenue is -0.17. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Myomo Inc, assuming nothing else is changed. The correlation between historical values of Myomo's Common Stock and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Myomo Inc are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Common Stock i.e., Myomo's Common Stock and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | -0.17 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Common Stock
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from Myomo's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Myomo Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. At this time, Myomo's Tax Provision is very stable compared to the past year. As of the 19th of May 2024, Enterprise Value is likely to grow to about 148.6 M, while Selling General Administrative is likely to drop about 10.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 10.3M | 10.3M | 13.2M | 13.8M | Total Revenue | 13.9M | 15.6M | 19.2M | 20.2M |
Myomo fundamental ratios Correlations
Click cells to compare fundamentals
Myomo Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Myomo fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.6M | 14.7M | 20.1M | 10.2M | 14.6M | 10.4M | |
Other Current Liab | 1.7M | 2.7M | 3.0M | 48.2K | 3.9M | 4.1M | |
Total Current Liabilities | 3.9M | 2.9M | 4.3M | 3.6M | 5.5M | 3.1M | |
Total Stockholder Equity | 1.8M | 11.6M | 15.4M | 6.4M | 9.0M | 4.9M | |
Net Tangible Assets | 1.8M | 11.6M | 15.4M | 6.4M | 7.3M | 7.7M | |
Property Plant And Equipment Net | 155.0K | 263.8K | 908.2K | 703.0K | 839.3K | 881.3K | |
Net Debt | (1.8M) | (12.1M) | (14.8M) | (4.8M) | (6.3M) | (6.6M) | |
Retained Earnings | (56.1M) | (67.7M) | (78.1M) | (88.8M) | (96.9M) | (92.1M) | |
Accounts Payable | 450.1K | 180.5K | 723.4K | 3.2M | 1.1M | 889.4K | |
Cash | 4.5M | 12.2M | 15.5M | 5.3M | 6.9M | 7.5M | |
Non Current Assets Total | 449.2K | 263.8K | 908.2K | 946.5K | 930.6K | 533.7K | |
Non Currrent Assets Other | 219.2K | (263.8K) | 95.3K | 111.0K | 91.2K | 97.0K | |
Other Assets | 294.2K | 263.8K | 19.8M | 111.0K | 127.7K | 121.3K | |
Cash And Short Term Investments | 4.5M | 12.2M | 15.5M | 5.3M | 8.9M | 7.7M | |
Net Receivables | 424.3K | 924.9K | 2.0M | 1.9M | 2.4M | 2.5M | |
Common Stock Shares Outstanding | 553.8K | 3.3M | 5.8M | 7.1M | 29.5M | 31.0M | |
Liabilities And Stockholders Equity | 6.6M | 14.7M | 20.1M | 10.2M | 14.6M | 10.4M | |
Non Current Liabilities Total | 890.5K | 274.7K | 402.9K | 200.7K | 115.2K | 109.4K | |
Capital Surpluse | 58.0M | 79.3M | 93.5M | 95.1M | 109.4M | 114.8M | |
Inventory | 439.5K | 707.1K | 808.3K | 1.4M | 1.8M | 1.9M | |
Other Current Assets | 820.2K | 572.7K | 894.5K | 573.5K | 598.9K | 530.4K | |
Other Stockholder Equity | 58.0M | 79.3M | 93.5M | 95.1M | 105.8M | 58.8M | |
Total Liab | 4.8M | 3.1M | 4.7M | 3.8M | 5.6M | 4.0M | |
Total Current Assets | 6.1M | 14.4M | 19.2M | 9.2M | 13.7M | 9.9M | |
Short Term Debt | 1.8M | 18.3K | 333.4K | 353.7K | 486.1K | 562.0K | |
Common Stock | 57.0 | 457.0 | 687.0 | 775.0 | 2.7K | 2.9K | |
Property Plant Equipment | 155.0K | 95.0K | 908.2K | 703.0K | 808.5K | 848.9K | |
Deferred Long Term Liab | 44.0K | 144.6K | 219.2K | 1.5K | 1.3K | 1.3K | |
Current Deferred Revenue | 3.0K | 2.5K | 192.8K | 20.7K | 8.5K | 8.1K | |
Common Stock Total Equity | 1.1K | 1.2K | 57.0 | 457.0 | 411.3 | 477.6 | |
Property Plant And Equipment Gross | 155.0K | 263.8K | 1.3M | 703.0K | 1.6M | 1.7M | |
Cash And Equivalents | 4.5M | 12.2M | 15.5M | 5.3M | 6.1M | 9.1M | |
Net Invested Capital | 4.5M | 11.6M | 15.4M | 6.4M | 9.0M | 10.3M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Myomo Stock analysis
When running Myomo's price analysis, check to measure Myomo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myomo is operating at the current time. Most of Myomo's value examination focuses on studying past and present price action to predict the probability of Myomo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Myomo's price. Additionally, you may evaluate how the addition of Myomo to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Myomo's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 0.652 | Quarterly Revenue Growth 0.177 | Return On Assets (0.42) | Return On Equity (1.06) |
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.